These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 25779942

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells.
    Croushore EE, Stipp CS, Gordon DJ.
    Int J Mol Sci; 2024 Aug 06; 25(16):. PubMed ID: 39201282
    [Abstract] [Full Text] [Related]

  • 23. Mithramycin A Radiosensitizes EWS:Fli1+ Ewing Sarcoma Cells by Inhibiting Double Strand Break Repair.
    Lin MY, Damron TA, Oest ME, Horton JA.
    Int J Radiat Oncol Biol Phys; 2021 Apr 01; 109(5):1454-1471. PubMed ID: 33373655
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.
    Mutz CN, Schwentner R, Aryee DNT, Bouchard EDJ, Mejia EM, Hatch GM, Kauer MO, Katschnig AM, Ban J, Garten A, Alonso J, Banerji V, Kovar H.
    Oncotarget; 2017 Apr 11; 8(15):24679-24693. PubMed ID: 28160567
    [Abstract] [Full Text] [Related]

  • 27. Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.
    Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, Khan J, Helman LJ.
    Neoplasia; 2011 Feb 11; 13(2):145-53. PubMed ID: 21403840
    [Abstract] [Full Text] [Related]

  • 28. Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors.
    Li Y, Li X, Fan G, Fukushi J, Matsumoto Y, Iwamoto Y, Zhu Y.
    Cancer Lett; 2012 Jul 01; 320(1):14-22. PubMed ID: 22266186
    [Abstract] [Full Text] [Related]

  • 29. ETS1, a Target Gene of the EWSR1::FLI1 Fusion Oncoprotein, Regulates the Expression of the Focal Adhesion Protein TENSIN3.
    Ebegboni VJ, Jones TL, Brownmiller T, Zhao PX, Pehrsson EC, Sundara Rajan S, Caplen NJ.
    Mol Cancer Res; 2024 Jul 02; 22(7):625-641. PubMed ID: 38588446
    [Abstract] [Full Text] [Related]

  • 30. USP19 deubiquitinates EWS-FLI1 to regulate Ewing sarcoma growth.
    Gierisch ME, Pedot G, Walser F, Lopez-Garcia LA, Jaaks P, Niggli FK, Schäfer BW.
    Sci Rep; 2019 Jan 30; 9(1):951. PubMed ID: 30700749
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing's sarcoma in vitro.
    Jully B, Vijayalakshmi R, Gopal G, Sabitha K, Rajkumar T.
    BMC Cancer; 2012 Nov 12; 12():513. PubMed ID: 23145994
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of platelet-derived growth factor-induced cell growth signaling by a short interfering RNA for EWS-Fli1 via down-regulation of phospholipase D2 in Ewing sarcoma cells.
    Nozawa S, Ohno T, Banno Y, Dohjima T, Wakahara K, Fan DG, Shimizu K.
    J Biol Chem; 2005 Jul 29; 280(30):27544-51. PubMed ID: 15919668
    [Abstract] [Full Text] [Related]

  • 35. GLI1 is a central mediator of EWS/FLI1 signaling in Ewing tumors.
    Joo J, Christensen L, Warner K, States L, Kang HG, Vo K, Lawlor ER, May WA.
    PLoS One; 2009 Oct 27; 4(10):e7608. PubMed ID: 19859563
    [Abstract] [Full Text] [Related]

  • 36. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
    Saulnier O, Guedri-Idjouadiene K, Aynaud MM, Chakraborty A, Bruyr J, Pineau J, O'Grady T, Mirabeau O, Grossetête S, Galvan B, Claes M, Al Oula Hassoun Z, Sadacca B, Laud K, Zaïdi S, Surdez D, Baulande S, Rambout X, Tirode F, Dutertre M, Delattre O, Dequiedt F.
    Nucleic Acids Res; 2021 May 21; 49(9):5038-5056. PubMed ID: 34009296
    [Abstract] [Full Text] [Related]

  • 37. RETRACTED: Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
    Lee HJ, Yoon C, Schmidt B, Park DJ, Zhang AY, Erkizan HV, Toretsky JA, Kirsch DG, Yoon SS.
    Mol Cancer Ther; 2013 Nov 21; 12(11):2591-600. PubMed ID: 23966622
    [Abstract] [Full Text] [Related]

  • 38. Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.
    Stoll G, Surdez D, Tirode F, Laud K, Barillot E, Zinovyev A, Delattre O.
    Nucleic Acids Res; 2013 Oct 21; 41(19):8853-71. PubMed ID: 23935076
    [Abstract] [Full Text] [Related]

  • 39. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW, Basse AN, Chandler GL, Kirk AM, Rakheja D, Amatruda JF.
    Dis Model Mech; 2012 Jan 21; 5(1):95-106. PubMed ID: 21979944
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
    Theisen ER, Pishas KI, Saund RS, Lessnick SL.
    Oncotarget; 2016 Apr 05; 7(14):17616-30. PubMed ID: 26848860
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.